Breakthrough Approval of Vykat XR: A Game-Changer in Treating Prader-Willi Syndrome’s Debilitating Hunger March 27, 2025
Revolutionary Approval of Vykat XR: A Breakthrough Treatment for Prader-Willi Syndrome Unleashes Hope for Patients and Families March 26, 2025
Dr. Martin Makary Confirmed as FDA Commissioner: Navigating Challenges and Transforming Public Health Regulation March 26, 2025
Revolutionizing Genetic Medicine: Epicrispr Biotechnologies Secures $68 Million to Tackle Muscular Dystrophy with Innovative Epigenetic Editing March 26, 2025
Merck’s $200 Million Gamble: Pioneering the Future of Oral Heart Disease Treatments with Innovative Lp(a) Therapy March 26, 2025
Merck’s $200 Million Bet on Oral Heart Medication Signals New Era in Cardiovascular Therapy March 26, 2025
Merck’s $200 Million Bet on Oral Cardiovascular Drug: A Game Changer in Heart Disease Treatment March 25, 2025
Merck’s Bold $200 Million Bet on Oral Heart Drug HRS-5346: A New Era in Cardiovascular Treatment March 25, 2025
Character Biosciences Secures $93 Million to Revolutionize AMD Treatment with Novel Drug Candidates March 25, 2025
Revolutionary Gene Editing Therapy VERVE-102 Receives FDA Approval to Transform Cholesterol Treatment Landscape March 25, 2025
